CoreCap Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
CoreCap Advisors's BCAT Position: Q2 2026 in Review
CoreCap Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 81% in Q2 2026, buying an estimated $330K and bringing the position to 48,146 shares worth $767K. The position accounts for 0.02% of the portfolio, ranked #444.
CoreCap Advisors first reported a position in BCAT in Q4 2022 and has held it in 11 quarters since. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- CoreCap Advisors held 48,146 shares of BlackRock Capital Allocation Term Trust worth $767K as of Q2 2026.
- CoreCap Advisors bought 21,482 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $330K.
- BlackRock Capital Allocation Term Trust made up 0.02% of CoreCap Advisors's portfolio in Q2 2026, its #444 holding.
- CoreCap Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and has held it in 11 quarters since.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.